Cryoport is the premier provider of cold chain logistics solutions for biopharmaceutical, IVF and animal health organizations around the world. Cryoport is the life science industry’s most trusted provider of supply chain solutions for temperature-sensitive materials, serving biopharmaceutical, IVF and surrogacy and animal health organizations around the world. Cryoport’s proprietary Cryoport Express® shippers, Cryoportal® Logistics Management Platform, leading-edge Smartpak II® Condition Monitoring System and geo-sensing technology paired with unparalleled logistics expertise and 24/7/365 customer support, make Cryoport the end-to-end cold chain logistics partner that you can trust. Cryoport is currently hiring and we’re looking for professionals who are committed to quality and continuous improvement. If you’re interested in working for a company that is passionate about transforming the life science industry by providing complete cold chain logistics solutions,
Cryoport
Unlock to Claim this listing
Add / Modify Company
3.4
Overall Excellence Rating
Industry
TransportationCategory
Regenerative MedicineESG/Ethical Impact
Beginning in 2020 we initiated a formal internal review of our ESG policies, procedures, and performance. Subsequently in February 2021, we publicly disclosed ESG information based on the framework and standards set by the Sustainability Accounting Standards Board (SASB) and the Taskforce on Climate-related Financial Disclosures (TCFD). Building upon our first report, we began with the goal of developing a formal, thoughtful, comprehensive, and right-sized sustainability program that would be used as a foundation for effectively organizing, reporting, and measuring our performance to set ESG goals in the future. In June 2021, we began a materiality assessment to guide our overall sustainability strategy. The intent of the materiality assessment was to understand what ESG topics were important to our key stakeholders, to take into consideration Cryoport’s business strategy development, and to understand Cryoport’s global internal priorities. There were three key activities for this phase of the process: Benchmarking against peer companies, ratings received from ISS, MSCI, and Sustainalytics, and interviews with key stakeholders. The information and feedback received from the materiality assessment was aggregated into a customized and weighted materiality matrix. The following Materiality Matrix follows GRI Standards recommendations and plots topics based on their relative priority resulting from the materiality assessment. Once the Materiality Matrix was developed, several meetings were conducted internally with our ESG committee and our Board of Directors’ Nomination and Governance Committee to evaluate the findings. As we proceeded on our ESG endeavour in 2022, our initial key focus was on Green House Gas (GHG) Emissions. GHG emissions were the foremost priority identified in our Materiality Matrix and represent a clear global significance for companies, consumers, and other stakeholders.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Awards Received
2023
Revenues
$962,500,000.00
Website Traffic
Employee Rating
3.6
Customer Rating
Company Size
100-1000
ESG Risk Rating
3